Ex-vivo response to blood products and haemostatic agents after paediatric cardiac surgery

Blood Coagulation and Fibrinolysis

Volumn 24, Issue 6, 2013, Pages 587-592

  Hvas, Anne Mette ^a   Andreasen, Jo B ^a   Christiansen, Kirsten ^a   Ravn, Hanne B ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

children; coagulation; congenital heart disease; haemostasis; thrombelastography

Indexed keywords

BLOOD CLOTTING FACTOR 13 CONCENTRATE; FIBRINOGEN CONCENTRATE; HEMOSTATIC AGENT; RECOMBINANT BLOOD CLOTTING FACTOR 7A; TRANEXAMIC ACID;

ARTICLE; BLOOD CLOTTING; BLOOD CLOTTING DISORDER; BLOOD CLOTTING TIME; EX VIVO STUDY; FEMALE; HEART SURGERY; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; THROMBOCYTE COUNT; THROMBOCYTE FUNCTION;

ADOLESCENT; BLOOD COAGULATION; BLOOD COAGULATION FACTORS; BLOOD TRANSFUSION; CARDIAC SURGICAL PROCEDURES; CHILD; CHILD, PRESCHOOL; FEMALE; HEMOSTATICS; HUMANS; INFANT; INFANT, NEWBORN; MALE; PLASMA; POSTOPERATIVE HEMORRHAGE; THROMBELASTOGRAPHY;

EID: 84882450064     PISSN: 09575235     EISSN: 14735733     Source Type: Journal    
DOI: 10.1097/MBC.0b013e32836029d2     Document Type: Article

References (28)

1. Ferraris VA, Brown JR, Despotis GJ, Hammon JW, Reece TB, Saha SP, et al. 2011 update to the Society of Thoracic Surgeons and the Society of Cardiovascular Anesthesiologists blood conservation clinical practice guidelines. Ann Thorac Surg 2011; 91:944-982.
2. Shore-Lesserson L, Manspeizer HE, DePerio M, Francis S, Vela-Cantos F, Ergin MA. Thromboelastography-guided transfusion algorithm reduces transfusions in complex cardiac surgery. Anesth Analg 1999; 88:312-319.
3. Sorensen B, Johansen P, Christiansen K, Woelke M, Ingerslev J. Whole blood coagulation thrombelastographic profiles employing minimal tissue factor activation. J Thromb Haemost 2003; 1:551-558.
4. Andreasen JB, Hvas AM, Christiansen K, Ravn HB. Can RoTEM (analysis be applied for haemostatic monitoring in paediatric congenital heart surgery Cardiol Young 2011; 21:684-691.
5. Romlin BS, Wahlander H, Berggren H, Synnergren M, Baghaei F, Nilsson K, Jeppsson A. Intraoperative thromboelastometry is associated with reduced transfusion prevalence in pediatric cardiac surgery. Anesth Analg 2011; 112:30-36.
6. Hayashi T, Sakurai Y, Fukuda K, Yada K, Ogiwara K, Matsumoto T, et al. Correlations between global clotting function tests, duration of operation, and postoperative chest tube drainage in pediatric cardiac surgery. Paediatr Anaesth 2011; 21:865-871.
7. Sorensen B, Asvaldsdottir HS, Gudmundsdottir BR, Onundarson PT. The combination of recombinant factor VIIa and fibrinogen correct clotting ex vivo in patient samples obtained following cardiopulmonary bypass surgery. Thromb Res 2009; 124:695-700.
8. Tanaka KA, Taketomi T, Szlam F, Calatzis A, Levy JH. Improved clot formation by combined administration of activated factor VII (NovoSeven) and fibrinogen (Haemocomplettan P). Anesth Analg 2008; 106:732-738.
9. Fenger-Eriksen C, Tonnesen E, Ingerslev J, Sorensen B. Recombinant factor VIIa and fibrinogen display additive effect during in vitro haemodilution with crystalloids. Acta Anaesthesiol Scand 2009; 53:332-338.
10. Despotis GJ, Joist JH, Goodnough LT. Monitoring of hemostasis in cardiac surgical patients: impact of point-of-care testing on blood loss and transfusion outcomes. Clin Chem 1997; 43:1684-1696.
11. Osthaus WA, Boethig D, Johanning K, Rahe-Meyer N, Theilmeier G, Breymann T, Suempelmann R. Whole blood coagulation measured by modified thrombelastography (ROTEM) is impaired in infants with congenital heart diseases. Blood Coagul Fibrinolysis 2008; 19:220-225.
12. Rapaport SI, Rao LV. The tissue factor pathway: how it has become a 'prima ballerina'. Thromb Haemost 1995; 74:7-17.
13. Roberts HR, Monroe DM, Escobar MA. Current concepts of hemostasis: implications for therapy. Anesthesiology 2004; 100:722-730.
14. Hoffman M, Monroe DM 3rd. A cell-based model of hemostasis. Thromb Haemost 2001; 85:958-965.
15. Karlsson M, Ternstrom L, Hyllner M, Baghaei F, Nilsson S, Jeppsson A. Plasma fibrinogen level, bleeding, and transfusion after on-pump coronary artery bypass grafting surgery: a prospective observational study. Transfusion 2008; 48:2152-2158.
16. Hiippala ST. Dextran and hydroxyethyl starch interfere with fibrinogen assays. Blood Coagul Fibrinolysis 1995; 6:743-746.
17. Fenger-Eriksen C, Moore GW, Rangarajan S, Ingerslev J, Sorensen B. Fibrinogen estimates are influenced by methods of measurement and hemodilution with colloid plasma expanders. Transfusion 2010; 50:2571-2576.
18. Gill R, Herbertson M, Vuylsteke A, Olsen PS, von Heymann C, Mythen M, et al. Safety and efficacy of recombinant activated factor VII: a randomized placebo-controlled trial in the setting of bleeding after cardiac surgery. Circulation 2009; 120:21-27.
19. Pychynska-Pokorska M, Pagowska-Klimek I, Krajewski W, Moll JJ. Use of recombinant activated factor VII for controlling refractory postoperative bleeding in children undergoing cardiac surgery with cardiopulmonary bypass. J Cardiothorac Vasc Anesth 2011; 25:987-994.
20. Karsies TJ, Nicol KK, Galantowicz ME, Stephens JA, Kerlin BA. Thrombotic risk of recombinant factor seven in pediatric cardiac surgery: a single institution experience. Ann Thorac Surg 2010; 89:570-576.
21. Agarwal HS, Bennett JE, Churchwell KB, Christian KG, Drinkwater DC Jr, He Y, Taylor MB. Recombinant factor seven therapy for postoperative bleeding in neonatal and pediatric cardiac surgery. Ann Thorac Surg 2007; 84:161-168.
22. Raghavan M, Marik PE. Anemia, allogenic blood transfusion, and immunomodulation in the critically ill. Chest 2005; 127:295-307.
23. Godje O, Gallmeier U, Schelian M, Grunewald M, Mair H. Coagulation factor XIII reduces postoperative bleeding after coronary surgery with extracorporeal circulation. Thorac Cardiovasc Surg 2006; 54:26-33.
24. Schroeder V, Kohler HP. Thrombelastographic studies on factor XIII. Thromb Haemost 2010; 104:1277-1279.
25. Tempe DK, Virmani S. Coagulation abnormalities in patients with cyanotic congenital heart disease. J Cardiothorac Vasc Anesth 2002; 16:752-765.
26. Gralnick HR. Epsilon-aminocaproic acid in preoperative correction of haemostatic defect in cyanotic congenital heart-disease. Lancet 1970; 1:1204-1205.
27. Williams GD, Bratton SL, Nielsen NJ, Ramamoorthy C. Fibrinolysis in pediatric patients undergoing cardiopulmonary bypass. J Cardiothorac Vasc Anesth 1998; 12:633-638.
28. Eaton MP. Antifibrinolytic therapy in surgery for congenital heart disease. Anesth Analg 2008; 106:1087-1100.